| Execution period | 60 months |
|---|
BSE filing, NSE: MANGALAM. Summary written from the filing by ALFA Finder's alert engine.
Mangalam Drugs and Organics Ltd: key numbers
- Share price
- ₹28.61
- Market cap
- ₹45.28 Cr
- Revenue (annual)
- ₹232.1 Cr
- Net profit (annual)
- ₹-44.40 Cr
- P/E (TTM)
- -1.2×Sector 45.9×
- Promoter holding
- 35.65%+0.00% QoQ
- FII holding
- 0.11%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Mangalam Drugs and Organics Ltd
All →Mangalam Drugs and Organics Board Meeting Date
Mangalam Drugs will hold a board meeting on 5 November 2026 to consider unaudited September 2026 quarter results. The agenda is proposed only, pending the meeting.
Mangalam Drugs and Organics Annual General Meeting
Mangalam Drugs issued a postal ballot notice seeking approval to re-appoint Praveen Saxena as independent director for a second five-year term. Voting closes 17 June 2026.
Mangalam Drugs and Organics Debt & Borrowing: ₹1,557 Cr
Mangalam Drugs and Organics Limited has reported a default amounting to Rs.1,557.27 Crore. The company has submitted a restructuring proposal to its banks to manage the obligation.
- Value
- ₹1,557 Cr
Mangalam Drugs and Organics Debt & Borrowing: ₹15.57 Cr
Mangalam Drugs and Organics Limited reported defaults on bank loan obligations totaling Rs. 15.57 Crore. The defaults involve cash credit accounts at Bank of Maharashtra and Bank of Baroda.
- Value
- ₹15.57 Cr
Mangalam Drugs and Organics Annual General Meeting
Mangalam Drugs and Organics Limited has issued a Postal Ballot notice to seek shareholder approval for appointing Shri Prabhakar Raghunath Zavar as an Independent Director. The appointment is for five years.
Mangalam Drugs and Organics Other Announcement
Mangalam Drugs and Organics Limited announced the appointment of new Statutory and Secretarial Auditors following the tenure completion of the previous Statutory Auditor.
Other management change announcements
All →NDA Securities Management Change
NDA Securities appointed Sudhir Kumar and Vivek Sarda as independent directors and Brijeshwar Patel as a non-executive director. Gungun Goel was named Company Secretary and Compliance Officer.
Home First Finance Company India Management Change
Home First Finance announced that Independent Director Anuj Srivastava vacated office on completing his five-year term, effective close of business on 31 October 2026. The filing is a director departure disclosed under Regulation 30.
Silver Touch Technologies Management Change
Silver Touch's independent director Piyushkumar Sinha resigned effective 30 Oct 2026, citing pre-occupation. No material reasons beyond this were disclosed.
Epuja Spiritech Management Change
Epuja Spiritech Ltd intimated the resignation of Sridhar Natrajan Chandrasekharan as Non-Executive Independent Director, effective November 2, 2026. The reason given is personal commitments and inability to devote sufficient time.
Marico Management Change
Marico's board appointed Mr. Rohit Jawa as Additional Independent Director for a five-year term. Shareholder approval will be sought via postal ballot.
Punjab & Sind Bank Management Change
Punjab & Sind Bank GM Thakur superannuated on 30 Sep 2026. Vinay Khandelwal appointed as GM from 1 Oct 2026.